2025-11-12
2025
• Initiate 3 IND-enabling studies
• Further strengthen the team and enhance corporate R&D capabilities
• Initiate Series A fundraising and BD engagements
2025-11-12
2023
• Strengthened organizational capacity
• Pipeline milestones progressing as planned
• Awarded “Technology-based SME title"